Catalyst Wire Dossier Catalyst Wire Dossier

fludarabine/rituximab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for fludarabine/rituximab, covering 2014-08-18 to 2014-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL) [Phase 2]

See pricing